Drugs / FMT
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04202211 Comparator | Mar 2022 → Dec 2024 | ulcerative colitis | University of British Columbia | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04202211 ↗ |
| Route | Oral | “lyophilized FMT given orally (10 capsules) twice weekly for total of 8 weeks” NCT04202211 ↗ |